{
    "clinical_study": {
        "@rank": "161525", 
        "arm_group": [
            {
                "arm_group_label": "Magnesium + Lipoic Acid", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate whether a combined supplementation of magnesium and lipoic acid is able to\n      significantly reduce the incidence of uterine contractions and related episodes of\n      hospitalization in pregnant women."
        }, 
        "brief_title": "Efficacy of Magnesium and Alpha Lipoic Acid Supplementation in Reducing Premature Uterine Contractions", 
        "condition": "Pregnancy", 
        "detailed_description": {
            "textblock": "Primary prevention of preterm labor is based on the early identification of risk factors and\n      on appropriate treatments. Although several drugs are currently used, the identification of\n      effective and safe agents able to improve both maternal and fetal health is still warranted.\n\n      In this study the efficacy a formulation based on  magnesium and alpha-lipoic acid has been\n      compared with placebo to evaluate the incidence of reduction of preterm delivery.\n\n      Three hundred pregnant women at 14-34 weeks of gestation were enrolled and randomly divided\n      to receive a daily single tablet containing magnesium and alpha-lipoic acid supplement or\n      placebo until delivery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  14-34 weeks of gestation\n\n        Exclusion Criteria:\n\n          -  Preexisting diabetes mellitus\n\n          -  Systolic blood pressure >140mm Hg\n\n          -  Cancer\n\n          -  lupus\n\n          -  hepatitis\n\n          -  HIV/AIDS\n\n          -  Diagnosed alcohol or chemical dependency"
            }, 
            "gender": "Female", 
            "maximum_age": "41 Years", 
            "minimum_age": "23 Years"
        }, 
        "firstreceived_date": "December 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02016495", 
            "org_study_id": "Mg-ALA"
        }, 
        "intervention": [
            {
                "arm_group_label": "Magnesium + Lipoic Acid", 
                "intervention_name": "Magnesium plus alpha-lipoic acid", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Thioctic Acid"
        }, 
        "lastchanged_date": "December 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Naples", 
                    "country": "Italy"
                }, 
                "name": "Clinica Villa delle Querce"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Number of women with sporadic episodes of preterm uterine contraction", 
                "time_frame": "From baseline (beginning of the treatment) until delivery"
            }, 
            {
                "measure": "Number of women with frequent and persistent episodes of preterm uterine contractions associated with pain", 
                "time_frame": "From baseline (beginning of the treatment) until delivery"
            }, 
            {
                "measure": "Number of women needed for hospital admission for threatened preterm labour", 
                "time_frame": "From baseline (beginning of the treatment) until delivery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02016495"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "AGUNCO Obstetrics and Gynecology Centre", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AGUNCO Obstetrics and Gynecology Centre", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}